Therefore, further investigation to elucidate the unidentified mechanisms influencing the effects of antidiabetic agents, FABPs, MITF and ANGPTL4 on diabetic states of MM by characterizing their down-stream signals using in vivo system such as a diabetic animal model needs to be conducted in the future. This evidence concerns the gene MITF and Miyoshi myopathy.